Search Results 351-360 of 17330 for Hypercalcemia

  1. Hypertrophic cardiomyopathy - Doctors and departments - Mayo Clinic

    In this condition, the heart muscle thickens, which makes it harder for the heart to pump blood. Learn about the causes and treatment.

  2. Mayo Clinic

    I've been on staff at the Mayo Clinic since 1997 and my whole career has really been focused on treating cancer. I'm Dr. Steven Alberts.

  3. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...

  4. Hypertrophic cardiomyopathy - Doctors and departments - Mayo Clinic

    In this condition, the heart muscle thickens, which makes it harder for the heart to pump blood. Learn about the causes and treatment.

  5. Myocardial Ischemia and Transfusion - Mayo Clinic

    Inclusion Criteria: 18 years of age or older; Either ST segment elevation myocardial infarction or Non ST segment elevation myocardial infarction consistent ...

  6. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  7. Conjugated estrogens and medroxyprogesterone (oral route) - Side effects & dosage - Mayo Clinic

    Hereditary angioedema (swelling of the face, mouth, or throat) or; Hypercalcemia (high calcium in the blood) or; Hypertension (high blood pressure) or ...

  8. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  9. A Multicenter Study Using Cryoablation for the Palliation of Painful Bone Metastases - Mayo Clinic

    These include bone pain, fractures, hypercalcemia, and spinal cord compression, all of which may profoundly impair a patient's quality of life. External ...

  10. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose ...